Pregnant women face worse care and coverage in abortion ban states

Pregnant women are more often uninsured and have worse access to routine medical care in states that ban (or restrict) abortion care, according to a new study appearing in the American Journal of Preventive Medicine, published by Elsevier, from researchers at Harvard Medical School, the City University of New York’s Hunter College, and other institutions. … Read more

Study highlights the lasting toll of colorectal cancer on women’s sexual health

A new University of British Columbia-led study is shedding light on a long-overlooked consequence of colorectal cancer: the lasting toll it can take on women’s sexual health, even years after treatment ends. Researchers analyzed health data from more than 25,000 women in B.C. diagnosed with colorectal cancer between 1985 and 2017, comparing their experiences to … Read more

Transfusion Strategies Show No QOL Improvement in Anemia Patients

Micah T. Prochaska, MD, MSc | Image Credit: University of Chicago School of Medicine A recent secondary analysis of data from the Myocardial Ischemia and Transfusion (MINT) trial has found no difference in quality of life (QOL) outcomes between liberal versus restrictive transfusion strategies in patients with myocardial infarction (MI) and anemia.1 Thanks to advances … Read more

South Lake County’s New Medical Facility

Archyde “`html New Urgent Care Center Planned for Coyote valley Plaza New Urgent Care Center Set to Open in Coyote Valley Plaza by 2026 Table of Contents 1. New Urgent Care Center Set to Open in Coyote Valley Plaza by 2026 2. Expanding Healthcare Access in Coyote Valley 3. Facility Details and expected Services 4. … Read more

Clairity BREAST receives FDA authorization for AI-based breast cancer risk prediction

Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025 … Read more

More expectant mothers begin pregnancy with autoimmune conditions

Thousands more UK women who are having children have been diagnosed with an autoimmune condition now compared to the beginning of the millennium. In a paper published in Lancet Rheumatology today, researchers involved in the MuM-PreDiCT project run by the University of Birmingham and funded by the Medical Research Council have found that there has … Read more

Are parents adapting to new allergy prevention advice for infants?

Despite strong evidence that early allergen exposure can prevent food allergies, new research shows most parents still wait. Study: Parental Motivation for Introducing Babies’ First Foods and Common Food Allergens. Image credit: shine.graphics/Shutterstock.com A study published in the journal Nutrients aimed to understand when and why parents introduce their infants to solid foods. Introduction Food allergy … Read more

Experts chart path to bring microbiome science into routine clinical care

As researchers unlock the diagnostic and therapeutic promise of the human microbiome, a new roadmap highlights the urgent need for standardization, better evidence, and clinician education to transform patient care. Perspective: The microbiome for clinicians. Image Credit: Kateryna Kon / Shutterstock A recent perspective published in the journal Cell outlines the challenges, opportunities, and necessary actions to … Read more

New studies offer hope for easing primary care doctor burnout

America’s primary care doctors are burning out, cutting back their hours, and leaving their practices early, driven in part by the demands of handling the flood of digital messages from their patients. But a trio of new University of Michigan studies offer hope for easing this crisis, and improving both the care that patients get … Read more

Secukinumab Demonstrates Long-Term Safety for Psoriasis and PsA

New findings from a real-world study has demonstrated long-term safety of secukinumab in people with psoriasis (PsO), psoriatic arthritis (PsA), and ankylosing spondylitis (AS).1 “Patients with immune-mediated inflammatory diseases such as PsO, PsA and AS, require prolonged treatment and are more susceptible to developing AEs as observed in clinical studies and case reports. Therefore, there … Read more